Delilah Hendriks

3.6k total citations · 2 hit papers
28 papers, 2.1k citations indexed

About

Delilah Hendriks is a scholar working on Molecular Biology, Hepatology and Surgery. According to data from OpenAlex, Delilah Hendriks has authored 28 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Hepatology and 7 papers in Surgery. Recurrent topics in Delilah Hendriks's work include Liver physiology and pathology (10 papers), Pluripotent Stem Cells Research (9 papers) and CRISPR and Genetic Engineering (8 papers). Delilah Hendriks is often cited by papers focused on Liver physiology and pathology (10 papers), Pluripotent Stem Cells Research (9 papers) and CRISPR and Genetic Engineering (8 papers). Delilah Hendriks collaborates with scholars based in Netherlands, Sweden and Switzerland. Delilah Hendriks's co-authors include Magnus Ingelman‐Sundberg, Benedetta Artegiani, Hans Clevers, Volker M. Lauschke, Catherine C. Bell, Susana M. Chuva de Sousa Lopes, Tommy B. Andersson, Åsa Nordling, Souren Mkrtchian and Christopher E. Goldring and has published in prestigious journals such as Cell, Nature Communications and Nature Biotechnology.

In The Last Decade

Delilah Hendriks

28 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease

2016 517 citations Catherine C. Bell, Delilah Hendriks et al. Scientific Reports profile →
Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis

2023 125 citations Delilah Hendriks, Jos F. Brouwers et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Delilah Hendriks Netherlands	19	780	746	693	419	418	28	2.1k
Simon Messner Switzerland	17	386 0.5×	446 0.6×	1.3k 1.9×	296 0.7×	764 1.8×	26	2.5k
Peggy Papeleu Belgium	18	378 0.5×	125 0.2×	957 1.4×	155 0.4×	172 0.4×	31	1.6k
Karl‐Dimiter Bissig United States	23	396 0.5×	173 0.2×	883 1.3×	76 0.2×	260 0.6×	43	1.8k
Guangfu Li United States	28	216 0.3×	183 0.2×	984 1.4×	30 0.1×	821 2.0×	96	2.4k
Baohong Zhang China	24	78 0.1×	137 0.2×	579 0.8×	46 0.1×	305 0.7×	77	1.6k
Dieter Paul Germany	20	188 0.2×	85 0.1×	731 1.1×	59 0.1×	216 0.5×	46	1.3k
Shinji Iwasaki Japan	22	371 0.5×	25 0.0×	530 0.8×	92 0.2×	353 0.8×	80	1.9k
Nai Yang Fu Singapore	26	68 0.1×	99 0.1×	1.5k 2.1×	91 0.2×	920 2.2×	43	2.3k
Jonathan Larkin United States	22	155 0.2×	66 0.1×	423 0.6×	28 0.1×	135 0.3×	45	1.4k

Countries citing papers authored by Delilah Hendriks

Since Specialization

Citations

This map shows the geographic impact of Delilah Hendriks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delilah Hendriks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delilah Hendriks more than expected).

Fields of papers citing papers by Delilah Hendriks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delilah Hendriks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delilah Hendriks. The network helps show where Delilah Hendriks may publish in the future.

Co-authorship network of co-authors of Delilah Hendriks

This figure shows the co-authorship network connecting the top 25 collaborators of Delilah Hendriks. A scholar is included among the top collaborators of Delilah Hendriks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delilah Hendriks. Delilah Hendriks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Artegiani, Benedetta, et al.. (2025). Generation of human fetal brain organoids and their CRISPR engineering for brain tumor modeling. Nature Protocols. 20(7). 1846–1883. 2 indexed citations

Artegiani, Benedetta, et al.. (2025). Emerging approaches to enhance human brain organoid physiology. Trends in Cell Biology. 35(6). 483–499. 6 indexed citations

Artegiani, Benedetta & Delilah Hendriks. (2025). Organoids from pluripotent stem cells and human tissues: When two cultures meet each other. Developmental Cell. 60(4). 493–511. 6 indexed citations

Hendriks, Delilah, Carmen López‐Iglesias, Jeff DeMartino, et al.. (2024). Human fetal brain self-organizes into long-term expanding organoids. Cell. 187(3). 712–732.e38. 52 indexed citations

Hendriks, Delilah, et al.. (2024). Mapping of mitogen and metabolic sensitivity in organoids defines requirements for human hepatocyte growth. Nature Communications. 15(1). 4034–4034. 17 indexed citations

Yang, Annie, Devanjali Dutta, Kai Kretzschmar, et al.. (2023). Development of Plasmodium falciparum liver-stages in hepatocytes derived from human fetal liver organoid cultures. Nature Communications. 14(1). 4631–4631. 13 indexed citations

Geurts, Maarten H., Shashank Gandhi, Matteo Boretto, et al.. (2023). One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids. Nature Communications. 14(1). 4998–4998. 32 indexed citations

Hendriks, Delilah, Jos F. Brouwers, Karien M. Hamer, et al.. (2023). Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis. Nature Biotechnology. 41(11). 1567–1581. 125 indexed citations breakdown →

Lopes, Susana M. Chuva de Sousa, et al.. (2023). Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss. Nature Communications. 14(1). 2377–2377. 22 indexed citations

10.

Ardisasmita, Arif Ibrahim, Imre F. Schene, Indi P. Joore, et al.. (2022). A comprehensive transcriptomic comparison of hepatocyte model systems improves selection of models for experimental use. Communications Biology. 5(1). 1094–1094. 15 indexed citations

11.

Artegiani, Benedetta, Delilah Hendriks, Joep Beumer, et al.. (2020). Fast and efficient generation of knock-in human organoids using homology-independent CRISPR–Cas9 precision genome editing. Nature Cell Biology. 22(3). 321–331. 210 indexed citations

12.

Hendriks, Delilah, Benedetta Artegiani, Huili Hu, Susana M. Chuva de Sousa Lopes, & Hans Clevers. (2020). Establishment of human fetal hepatocyte organoids and CRISPR–Cas9-based gene knockin and knockout in organoid cultures from human liver. Nature Protocols. 16(1). 182–217. 119 indexed citations

13.

Hendriks, Delilah, Hans Clevers, & Benedetta Artegiani. (2020). CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids. Cell stem cell. 27(5). 705–731. 126 indexed citations

14.

Baze, Audrey, C. Parmentier, Delilah Hendriks, et al.. (2018). Three-Dimensional Spheroid Primary Human Hepatocytes in Monoculture and Coculture with Nonparenchymal Cells. Tissue Engineering Part C Methods. 24(9). 534–545. 70 indexed citations

15.

Parmentier, C., Delilah Hendriks, Bruno Heyd, et al.. (2018). Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent. Toxicology Letters. 295. 187–194. 18 indexed citations

16.

Hendriks, Delilah, et al.. (2016). Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability. Scientific Reports. 6(1). 35434–35434. 122 indexed citations

17.

Bell, Catherine C., Delilah Hendriks, Sabrina Moro, et al.. (2016). Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Scientific Reports. 6(1). 25187–25187. 517 indexed citations breakdown →

18.

Hendriks, Delilah, et al.. (2016). 3D hepatic spheroid models for the detection and study of compounds with cholestatic liability. Toxicology Letters. 258. S134–S135. 1 indexed citations

19.

Neve, Etienne P.A., Harald Köfeler, Delilah Hendriks, et al.. (2015). Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran. PLoS ONE. 10(9). e0138487–e0138487. 24 indexed citations

20.

Hendriks, Delilah, et al.. (2014). Human NAD(P)H:quinone Oxidoreductase 1 (NQO1)-Mediated Inactivation of Reactive Quinoneimine Metabolites of Diclofenac and Mefenamic Acid. Chemical Research in Toxicology. 27(4). 576–586. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact